Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00785551 · ClinicalTrials.gov registry record · Phase 1
Comparative Study of Quinine Sulfate in Healthy Patients and in Patients With Renal Impairment
A Phase 1 study, sponsored by Mutual Pharmaceutical Company.
- Terminated
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT00785551: Clinical Trial Phase 1 study, sponsored by Mutual Pharmaceutical Company.
NCT00785551 is a Phase 1 study that was terminated before completion, run by Mutual Pharmaceutical Company. The registered enrollment target is 5 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00785551, a Phase 1 study, was terminated before completion, sponsored by Mutual Pharmaceutical Company.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The effects of mild or moderate renal impairment (creatinine clearance 30 to 50 ml/min or \>50 to 80 ml/min, respectively) on the pharmacokinetic profile of quinine and its active metabolite, 3'-hydroxyquinine, will be investigated. Safety and tolerability in healthy subjects versus those with mild to moderate renal impairment will be compared, as well.
Interventions
- DRUG quinine sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-01 |
| Phase | Phase 1 |
Why NCT00785551 stopped before completion
NCT00785551 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which quinine sulfate is the first listed.
NCT00785551 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00785551 about?
NCT00785551 is a clinical study titled "Comparative Study of Quinine Sulfate in Healthy Patients and in Patients With Renal Impairment". The effects of mild or moderate renal impairment (creatinine clearance 30 to 50 ml/min or \>50 to 80 ml/min, respectively) on the pharmacokinetic profile of quinine and its active metabolite, 3'-hydroxyquinine, will be investigated. Safety and tolerability in healthy subjects versus those with mild ...
What is the current status of trial NCT00785551?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2007-11. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00785551?
The interventions under investigation include: quinine sulfate (DRUG).
Who is sponsoring clinical trial NCT00785551?
This trial is sponsored by Mutual Pharmaceutical Company, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00785551's enrollment target sits among peer trials
5 1989th of 2000 higher than 6 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia